Wikio - Teva Pharmaceutical Industries

Azilect data points to Parkinson's efficacy (Fiercebiotech)

Tue, 26 Aug 2008 15:12:18 GMT

Teva Pharmaceutical is touting the results of a late-stage study of Azilect, a treatment for Parkinson's disease. Researchers say the therapy hit all of its goals in the ADAGIO trial. Patients taking a once-daily oral dose of the drug reported a slowing of disease progression early on in the trial with a reduction in symptoms at a later point in the trial. The drug is already approved...

Source : Fiercebiotech (subscribe)

Explore : Diseases, Parkinson's Disease

Merger Watch: Barr Pharmaceuticals - Teva Pharmaceutical (Seeking Alpha)

Fri, 22 Aug 2008 07:07:07 GMT

The M & A Researcher submits: First, this August 14 Financial Times article will be referenced as it essentially echoes this publication's original assessment of the Barr Pharmaceuticals (BRL) - Teva Pharmaceutical (TEVA) transaction upon announcement last month. Of particular interest in this piece are the following passages from an third-part analytical report: An analyst...

Source : Seeking Alpha (subscribe)

Explore : Barr Pharmaceuticals, China, Drug Manufacturers, Financial Times

Cel-Sci inks deal with Teva; Pharmaxis touts Phase III data; BioCenter expands (Fiercebiotech)

Wed, 20 Aug 2008 14:47:16 GMT

> Cel-Sci has struck a development and commercialization deal with Teva Pharmaceutical for the cancer drug Multikine. Release > Pharmaxis announced that the Phase III clinical trial evaluating the long term safety of Bronchitol in subjects with bronchiectasis has concluded with no serious adverse events attributed to the drug following 12 months of treatment. Release > San Jose BioCenter,...

Source : Fiercebiotech (subscribe)

Stada climbs on report Teva in talks to buy it (Market Watch)

Fri, 15 Aug 2008 08:18:23 GMT

LONDON (MarketWatch) -- Shares of Stada Arzneimittel rose 12%after the Israeli online financial site Globes reported that Teva Pharmaceutical is in talks to buy Germany's third-largest generics maker even before the Barr Pharmaceuticals deal closes. The report cited unnamed sources and said neither company commented. The site noted that Teva's CEO Shlomo Yanay previously...

Source : Market Watch (subscribe)

Explore : Barr Pharmaceuticals, Markets

Israel Stocks: ICL surges again; Delek Group reiterated a buy (Market Watch)

Tue, 22 Jul 2008 14:38:00 GMT

Israeli stocks fell on Tuesday, snapping a three-session winning streak, with the banks and Teva Pharmaceutical leading the losers and Israel Chemicals rising for a second day after an analyst upgrade.

Source : Market Watch (subscribe)

Explore : Finance, Israel

Teva Pharmaceutical goes bargain hunting, picks up Barr Pharmaceuticals for $7.46b :: israelplug - innovations. made in israel. (Israelated)

Tue, 22 Jul 2008 08:27:35 GMT

According to Haaretz, Teva has been going on a “little” shopping spree, buying companies as if they were cute pairs of shoes they just had to have. (And FYI, this Teva company has no connection to the Israeli hikers’ beloved Teva sandal co., incidentally made in China.) Recently, Teva purchased Barr Pharmaceuticals, “the fourth largest generic firm in the U.S., for...

Source : Israelated (subscribe)

Explore : Barr Pharmaceuticals, Drug Manufacturers, Generic Drugs, Israel

Israel Stocks: Market higher; Israel Chemicals and Teva upgraded (Market Watch)

Mon, 21 Jul 2008 14:31:00 GMT

Israel stocks rise strongly, helped by broker upgrades at Israel Chemicals and at Teva Pharmaceutical in the wake of its bid to acquire Barr Pharmaceuticals.

Source : Market Watch (subscribe)

Explore : Barr Pharmaceuticals, Financial Services, Israel

Teva Pharmaceutical upgraded to buy at Deutsche Bank (Market Watch)

Mon, 21 Jul 2008 11:41:32 GMT

LONDON (MarketWatch) -- Deutsche Bank upgraded Teva Pharmaceutical Industries to buy from hold, saying the group's plan to purchase Barr Pharmaceuticals Inc. for around $7.5 billion will enhance its growth prospects over the next four years. "Strategically, this transaction makes a lot of sense given little overlap in the two companies' businesses. First, Teva would benefit...

Source : Market Watch (subscribe)

Explore : Barr Pharmaceuticals, Deutsche Bank, Drug Manufacturers, Markets

Teva buying Barr Pharma in deal valued at $7B (Indy Star)

Sat, 19 Jul 2008 05:00:00 GMT

TRENTON, N.J. » Teva Pharmaceutical said Friday it will buy rival generic drug maker Barr Pharmaceuticals for nearly $7.5 billion in a move that will boost Teva's dominance as the world's biggest generic drug maker.

Source : Indy Star (subscribe)

Explore : Barr Pharmaceuticals, Business, Drug Manufacturers, Generic Drugs, Trenton

Teva to buy Barr Pharmaceuticals (Baltimore Sun)

Sat, 19 Jul 2008 04:00:00 GMT

Teva Pharmaceutical said yesterday that it would buy rival generic drugmaker Barr Pharmaceuticals for nearly $7.5 billion.

Source : Baltimore Sun (subscribe)

Explore : Barr Pharmaceuticals, Business, Generic Drugs

Teva Pharmaceutical to Buy Barr Pharmaceuticals for $7.46B, plus Debt (Hispanic Business Magazine)

Fri, 18 Jul 2008 14:38:19 GMT

NEW YORK (Thomson Financial) - Teva Pharmaceutical Industries Ltd. Friday said it reached a definitive agreement to buy Barr Pharmaceuticals Inc. for a total consideration of $7.46 billion as well as the assumption of $1.5 billion in net debt....

Source : Hispanic Business Magazine (subscribe)

Explore : Barr Pharmaceuticals, Cities and Towns, New York, New York City

Teva Pharmaceutical Agrees to Buy Barr (Red Orbit )

Fri, 18 Jul 2008 14:01:12 GMT

Teva Pharmaceutical Industries Ltd. of Israel said Friday it had agreed to purchase Barr Pharmaceuticals Inc., in a deal valued at $8.96 billion.

Source : Red Orbit (subscribe)

Explore : Barr Pharmaceuticals, Drug Manufacturers, Generic Drugs, Health

Teva to buy Barr for $7B as generic-drug makers team up (USA Today)

Fri, 18 Jul 2008 13:13:15 GMT

Israeli drugmaker Teva Pharmaceutical said Friday it will buy rival generic drug company Barr Pharmaceuticals for more than $7 ...

Source : USA Today (subscribe)

Explore : Barr Pharmaceuticals, Drug Manufacturers, Finance, Generic Drugs

Teva to buy Barr Pharma for more than $7B (MSNBC.com)

Fri, 18 Jul 2008 12:58:21 GMT

Israeli drugmaker Teva Pharmaceutical said it will buy rival generic drug company Barr Pharmaceuticals for more than $7 billion.

Source : MSNBC.com (subscribe)

Explore : Barr Pharmaceuticals, Business, Drug Manufacturers, Generic Drugs

Drugmaker Teva to buy rival for $7 billion (International Herald Tribune)

Fri, 18 Jul 2008 12:49:57 GMT

The Israeli drugmaker Teva Pharmaceutical said Friday it will buy rival generic drug company Barr Pharmaceuticals for more than $7 billion in a move to expand its presence in U.S. and Eastern European markets.

Source : International Herald Tribune (subscribe)

Explore : Barr Pharmaceuticals, Drug Manufacturers, Europe, Generic Drugs, World Markets

Teva to buy Barr Pharma for $7 billion-plus (atHome Top Story)

Fri, 18 Jul 2008 12:35:41 GMT

Israeli drug-maker Teva Pharmaceutical said Friday it will buy rival generic drug company Barr Pharmaceuticals for more than $7 billion (U.S.) in a move to expand its presence in U.S. and Eastern European markets.

Source : atHome Top Story (subscribe)

Explore : Barr Pharmaceuticals, Drug Manufacturers, Europe, Generic Drugs, World Markets

Teva Pharmaceutical to buy Barr for $7.5bn (FT.com - Europe homepage)

Fri, 18 Jul 2008 12:24:00 GMT

Teva, the Israeli generic drugs group, is to acquire Barr of the US in a $7.5bn deal that will strongly reinforce its position as the world's largest seller of off-patent medicines

Source : FT.com - Europe homepage (subscribe)

Explore : Drug Manufacturers, Generic Drugs

Teva to expand in U.S., Europe via $7.5 billion deal for Barr (Market Watch)

Fri, 18 Jul 2008 12:19:00 GMT

Teva Pharmaceutical agrees to buy smaller generics rival Barr Pharmaceuticals Ifor $7.46 billion plus about $1.5 billion in assumed debt.

Source : Market Watch (subscribe)

Explore : Barr Pharmaceuticals, Europe, Finance

Teva to buy Barr Pharma for more than $7 billion (Seattle Times)

Fri, 18 Jul 2008 12:15:10 GMT

Israeli drugmaker Teva Pharmaceutical said Friday it will buy rival generic drug company Barr Pharmaceuticals for more than $7 billion in a move to expand its presence in U.S. and Eastern European markets.

Source : Seattle Times (subscribe)

Explore : Barr Pharmaceuticals, Business, Drug Manufacturers, Generic Drugs, World Markets

Teva to buy Barr Pharma for more than $7 billion (Examiner)

Fri, 18 Jul 2008 11:39:55 GMT

Israeli drugmaker Teva Pharmaceutical says it will buy rival generic drug company Barr Pharmaceuticals for more than $7 billion, in a move to expand its presence in U.S. and Eastern European markets.

Source : Examiner (subscribe)

Explore : Barr Pharmaceuticals, Business, Drug Manufacturers, Generic Drugs, World Markets